🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
Ogsiveo 50 mg film‑coated tablets
EU/1/25/1932/001-002
Nirogacestat hydrobromide Springworks Therapeutics Ireland Limited
OKEDI 100 mg Powder and solvent for prolonged-release suspension for injection
EU/1/21/1621/002
Risperidone Laboratorios Farmacéuticos ROVI, S.A.
OKEDI 75 mg Powder and solvent for prolonged-release suspension for injection
EU/1/21/1621/001
Risperidone Laboratorios Farmacéuticos ROVI, S.A.
Olanzapine Apotex 10 mg film-coated tablets
EU/1/10/635/006-7
Olanzapine Apotex Europe B.V.
Olanzapine Apotex 10 mg orodispersible tablets
EU/1/10/635/010-11
Olanzapine Apotex Europe B.V.
Olanzapine Apotex 15 mg orodispersible tablets
EU/1/10/635/012
Olanzapine Apotex Europe B.V.
Olanzapine Apotex 2.5 mg film-coated tablets
EU/1/10/635/001
Olanzapine Apotex Europe B.V.
Olanzapine Apotex 20 mg orodispersible tablets
EU/1/10/635/013-14
Olanzapine Apotex Europe B.V.
Olanzapine Apotex 5 mg film-coated tablets
EU/1/10/635/002-3
Olanzapine Apotex Europe B.V.
Olanzapine Apotex 5 mg orodispersible tablets
EU/1/10/635/008-9
Olanzapine Apotex Europe B.V.
Olanzapine Apotex 7.5 mg film-coated tablets
EU/1/10/635/004-5
Olanzapine Apotex Europe B.V.
Olanzapine Glenmark 10 mg tablets
EU/1/09/587/10-12
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark 15 mg tablets
EU/1/09/587/13-15
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark 2.5 mg tablets
EU/1/09/587/1-3
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark 20 mg tablets
EU/1/09/587/16-17
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark 5 mg tablets
EU/1/09/587/4-6
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark 7.5 mg tablets
EU/1/09/587/7-9
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark Europe 10 mg orodispersible tablets
EU/1/09/588/4-6
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark Europe 15 mg orodispersible tablets
EU/1/09/588/7-9
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark Europe 20 mg orodispersible tablets
EU/1/09/588/10-12
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Glenmark Europe 5 mg orodispersible tablets
EU/1/09/588/1-3
Olanzapine Glenmark Arzneimittel GmbH
Olanzapine Mylan 2.5 mg film-coated tablets
EU/1/08/475/1-6
Olanzapine Mylan Pharmaceuticals Limited
Olanzapine Mylan 10 mg film-coated tablets
EU/1/08/475/18-24
Olanzapine Mylan Pharmaceuticals Limited
Olanzapine Mylan 15 mg film-coated tablets
EU/1/08/475/25-29
Olanzapine Mylan Pharmaceuticals Limited
Olanzapine Mylan 20 mg film-coated tablets
EU/1/08/475/30-34
Olanzapine Mylan Pharmaceuticals Limited
Olanzapine Mylan 5 mg film-coated tablets
EU/1/08/475/7-12
Olanzapine Mylan Pharmaceuticals Limited
Olanzapine Mylan 7 mg film-coated tablets
EU/1/08/475/13-17
Olanzapine Mylan Pharmaceuticals Limited
Olanzapine Teva 10 mg film-coated tablets
EU/1/07/427/11-14
Olanzapine Teva Pharma B.V.
Olanzapine Teva 15 mg film-coated tablets
EU/1/07/427/16-19
Olanzapine Teva Pharma B.V.
Olanzapine Teva 2.5 mg film-coated tablets
EU/1/07/427/1-3
Olanzapine Teva Pharma B.V.
Olanzapine Teva 20 mg film-coated tablets
EU/1/07/427/20-22
Olanzapine Teva Pharma B.V.
Olanzapine Teva 5 mg film-coated tablets
EU/1/07/427/004-007
Olanzapine Teva Pharma B.V.
Olanzapine Teva 10 mg Orodispersible tablet
EU/1/07/427/27-30
Olanzapine Teva Pharma B.V.
Olanzapine Teva 15 mg Orodispersible tablet
EU/1/07/427/31-34
Olanzapine Teva Pharma B.V.
Olanzapine Teva 20 mg Orodispersible tablet
EU/1/07/427/35-37
Olanzapine Teva Pharma B.V.
Olanzapine Teva 5 mg Orodispersible tablet
EU/1/07/427/23-26
Olanzapine Teva Pharma B.V.
Olanzapine Teva 7.5 mg film-coated tablets
EU/1/07/427/008-010
Olanzapine Teva Pharma B.V.
Olazax 10 mg tablets
EU/1/09/597/003
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax 15 mg tablets
EU/1/09/597/004
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax 20 mg tablets
EU/1/09/597/005
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax 5 mg tablets
EU/1/09/597/001
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax 7.5 mg tablets
EU/1/09/597/002
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi
EU/1/09/592/002
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 10 mg orodispersible tablets
EU/1/09/592/003
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 15 mg orodispersible tablets
EU/1/09/592/004
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 20 mg orodispersible tablets
EU/1/09/592/005
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 5 mg orodispersible tablets
EU/1/09/592/001
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olbas Inhaler nasal stick
PA22702/002/003
Cajuput oil, Levomenthol, Eucalyptus oil, Peppermint oil LanesHealth (Ireland) Limited Marketed
Olbas Oil
PA22702/002/001
Cajuput oil, Clove oil, Eucalyptus oil, Juniper oil, Mint oil, partly dementholised LanesHealth (Ireland) Limited Marketed
Olumiant 1 mg film-coated tablets
EU/1/16/1170/017-019
Baricitinib Eli Lilly Nederland B.V.
52 53 54 55 56 57 58
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.